http://www.fpnotebook.com/

Hib Vaccine

Aka: Hib Vaccine, Haemophilus influenzae B Vaccine

Mechanism
1. Conjugated protein Vaccine
Preparations
1. HIBTITER (HbOC)
2. PedvaxHIB (PRP-OMP)
3. ActHIB (PRP-T)
Primary Series
1. Dose 1: Age 2 months
2. Dose 2: Age 4 months
3. Dose 3: Age 6 months
4. Dose 4: Age 12 to 15 months
Adverse Effects
1. No serious side effects
2. References
  1. (1996) MMWR Morb Mortal Wkly Rep 45(No. RR-12):1-35

Haemophilus influenzae type b polysaccharide vaccine (C0062086)
Concepts	Pharmacologic Substance (T121) , Immunologic Factor (T129)
MSH	C044237
SnomedCT	333680004, 412374001
English	Haemophilus influenzae type b polysaccharide vaccine, HIB-vaccine, HIB - Hemophilus influenzae Type B vaccine, HIB vaccine, Haemophilus influenzae Type b, Hemophilus influenzae Type b, Hemophilus influenzae Type b vaccine, Haemophilus influenzae type B vaccine, Haemophilus influenzae type b polyribosylribitol phosphate capsular polysaccharide vaccine, Hemophilus influenzae type b vaccine, hib vaccine, Haemophilus influenzae Type b vaccine (product), Haemophilus influenzae Type b vaccine (substance), Haemophilus influenzae type b vaccine (substance), Haemophilus influenzae type b vaccine, HIB - Haemophilus influenzae Type B vaccine, Haemophilus influenzae Type b vaccine
Spanish	vacuna anti-Haemophilus influenzae tipo b (producto), vacuna anti-Haemophilus influenzae tipo b, vacuna anti-Haemophilus influenzae tipo b (sustancia)
Sources	Derived from the NIH UMLS (Unified Medical Language System)

Family Practice Notebook

Patients should address specific medical concerns with their physicians.

Although access to this page is not restricted, the information found here is intended for use by medical providers.

This page was written by Scott Moses, MD, last revised on 10/21/2007 and last published on 5/14/2013.

This is one of 5887 pages in the Family Practice Notebook